[ET Net News Agency, 8 January 2024] JD HEALTH (06618) fell 3.1% to HK$33.35.
It hits an intra-day low of HK$33.35, hitting an 1-month low, and an intra-day high of
HK$34.7. The total shares traded was 1.24 million, with a value of HK$41.97m. The active
buy/sell ratio is 51:49, with net buying turnover of HK$483,342. CHINA INT'L CAPITAL CORP
HK accounts for greatest net responsive buying turnover of HK$2.3m, with volume weighted
average price of HK$33.87. MORGAN STANLEY HK SEC accounts for greatest net responsive
selling turnover of HK$3.53m, with volume weighted average price of HK$34.034. The stock
has fallen a combined 15.2% over the past 6 consecutive trading days.
RMB counter of JD HEALTH (86618) fell 3.5% to RMB30.7. It hits an intra-day low of
RMB30.9, and an intra-day high of RMB31. The total shares traded was 900, with a value of
RMB27,860.
The Hang Seng Index now fell 322 points, or 2% to 16,212; the Hang Seng China
Enterprises Index now fell 131 points, or 2.3% to 5,475; the Hang Seng TECH Index now fell
118 points, or 3.3% to 3,474.

Basic Information
=================

---------------------------------
Nominal 33.350 % Chg -3.05%
High 34.700 Low 33.350
Shares Tr 1.24m Turnover 41.97m
10-D SMA 36.745 %H.V 43.045
20-D SMA 37.005 VWAP 33.897
50-D SMA 37.469 RSI14 34.366
---------------------------------
Status: Hitting an 1-month low, active buy/sell ratio is 51:49, with net buying turnover
of HK$483,342, falling a combined 15.2% over the past 6 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
JD HEALTH (06618) 33.35 -3.05
ALI HEALTH (00241) 3.74 -3.36
TRAD CHI MED (00570) 3.40 -11.92
CSPC PHARMA (01093) 6.97 -2.79
SINOPHARM (01099) 19.68 -1.20
SINO BIOPHARM (01177) 3.27 -1.21
CHINARES PHARMA (03320) 5.30 -2.75
HANSOH PHARMA (03692) 13.54 -2.73
SCICLONE PHARMA (06600) 13.22 -7.55
JD HEALTH-R (86618) RMB30.70 -3.46
-----------------------------------------------
(ed)